
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 224 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Comparing New-User Cohort Designs: The Example of Proton Pump Inhibitor Effectiveness in Idiopathic Pulmonary Fibrosis”, Am J Epidemiol, 2020.
, “Comparison of antibiotic prescribing records in two UK primary care electronic health record systems: cohort study using CPRD GOLD and CPRD Aurum databases”, BMJ Open, vol. 10, p. e038767, 2020.
, “Comparison of antihypertensive drug classes for dementia prevention”, Epidemiology, 2020.
, “Comparison of long-term use of prolonged-release ropinirole and immediate-release dopamine agonists in an observational study in patients with Parkinson's disease”, Pharmacoepidemiol Drug Saf, 2020.
, “Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study”, Wellcome Open Res, vol. 5, p. 77, 2020.
, “Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study”, Ann Rheum Dis, 2020.
, “Concordance in the recording of stroke across UK primary and secondary care datasets: a population-based cohort study”, BJGP Open, 2020.
, “Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: longitudinal cohort study using cardiovascular disease as exemplar”, Bmj, vol. 371, p. m3919, 2020.
, “Co-prescription of gabapentinoids and opioids among adults with and without osteoarthritis in the United Kingdom between 1995 and 2017”, Rheumatology (Oxford), 2020.
, “Costs of joint replacement in osteoarthritis: a study using the National Joint Registry and Clinical Practice Research Datalink datasets”, Arthritis Care Res (Hoboken), 2020.
, “Cough presentation in primary care and the identification of chronic cough: a need for diagnostic clarity?”, Curr Med Res Opin, vol. 36, pp. 139-150, 2020.
, “Could dementia be detected from UK primary care patients' records by simple automated methods earlier than by the treating physician? A retrospective case-control study”, Wellcome Open Res, vol. 5, p. 120, 2020.
, “CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities”, Pharmacoepidemiol Drug Saf, 2020.
, “Data-driven discovery of changes in clinical code usage over time: a case-study on changes in cardiovascular disease recording in two English electronic health records databases (2001-2015)”, BMJ Open, vol. 10, p. e034396, 2020.
, “Deep learning for electronic health records: A comparative review of multiple deep neural architectures”, J Biomed Inform, vol. 101, p. 103337, 2020.
, “Delays in referral from primary care worsen survival for patients with colorectal cancer: a retrospective cohort study”, Br J Gen Pract, vol. 70, pp. e463-e471, 2020.
, , “Determinants of referral of women with urinary incontinence to specialist services: a national cohort study using primary care data from the UK”, BMC Fam Pract, vol. 21, p. 211, 2020.
, “Determination of healthcare resource and cost implications of using alternative sodium valproate formulations in the treatment of epilepsy in children in England: a retrospective database review”, Eur J Pharm Biopharm, 2020.
, “Development and Validation of a Clinical Prediction Tool for Seasonal Influenza Vaccination in England”, JAMA Netw Open, vol. 3, p. e207743, 2020.
, “Development and Validation of a Method to Estimate COPD Severity in Multiple Datasets: A Retrospective Study”, Pulm Ther, 2020.
, “Development and validation of a multivariable prediction model for infection-related complications in patients with common infections in UK primary care and the extent of risk-based prescribing of antibiotics”, BMC Med, vol. 18, p. 118, 2020.
, “Development and validation of the Cambridge Multimorbidity Score”, Cmaj, vol. 192, pp. E107-e114, 2020.
, “Development and validation of the DIabetes Severity SCOre (DISSCO) in 139 626 individuals with type 2 diabetes: a retrospective cohort study”, BMJ Open Diabetes Res Care, vol. 8, 2020.
, “Development of a structured clinical pharmacology review for specialist support for management of complex polypharmacy in primary care”, Br J Clin Pharmacol, 2020.
, “The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study”, PLoS Med, vol. 17, p. e1003295, 2020.
, “Disease Activity in Inflammatory Bowel Disease Is Associated With Arterial Vascular Disease”, Inflamm Bowel Dis, 2020.
, “Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study”, PLoS Med, vol. 17, p. e1003432, 2020.
, “The economic burden of infections following intramedullary nailing for a tibial shaft fracture in England”, BMJ Open, vol. 10, p. e035404, 2020.
, “Effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study”, Eur Heart J, 2020.
, “The effect of initiation of renin-angiotensin system inhibitors on haemoglobin: A national cohort study”, Br J Clin Pharmacol, 2020.
, “Effect of pre-existing conditions on bladder cancer stage at diagnosis: a cohort study using electronic primary care records in the UK”, Br J Gen Pract, 2020.
, “The effectiveness of frequent antibiotic use in reducing the risk of infection-related hospital admissions: results from two large population-based cohorts”, BMC Med, vol. 18, p. 40, 2020.
, “Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs”, Rheumatology (Oxford), 2020.
, “Effectiveness of proton pump inhibitors in idiopathic pulmonary fibrosis: a population-based cohort study”, Chest, 2020.
, “Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data”, BMJ Open, vol. 10, p. e033866, 2020.
, “Epidemiology and determinants of non-diabetic hyperglycaemia and its conversion to type 2 diabetes mellitus, 2000-2015: cohort population study using UK electronic health records”, BMJ Open, vol. 10, p. e040201, 2020.
, , , “Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research Datalink”, Rheumatology (Oxford), 2020.
, “Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study”, BMJ Open, vol. 10, p. e043828, 2020.
, “Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study”, Lancet, vol. 395, pp. 1715-1725, 2020.
, “Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United Kingdom”, Eur J Prev Cardiol, p. 2047487319899212, 2020.
, “Ethnic differences in the severity and clinical management of type 2 diabetes at time of diagnosis: A cohort study in the UK Clinical Practice Research Datalink”, Diabetes Res Clin Pract, vol. 160, p. 108006, 2020.
, “Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study”, PLoS Med, vol. 17, p. e1003106, 2020.
, “Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries”, Clin Epidemiol, vol. 12, pp. 423-433, 2020.
, “Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England”, JAMA Neurol, 2020.
, “Examining the impact of data quality and completeness of electronic health records on predictions of patients' risks of cardiovascular disease”, Int J Med Inform, vol. 133, p. 104033, 2020.
, , ,